Pressmeddelande

BioStock: Respiratorius' H1 marked by positive patent decision and secured financing

Cision Publicerad: 13 Aug 08:45

Respiratorius' half-year report for 2024 highlights the positive decision from the Patent Trial and Appeal Board regarding the company's US patent application for the formulation of VAL001. Additionally, Respiratorius has secured capital through a rights issue expected to ensure the company’s operations for the next two years. The company now has continued hopes of finding a partner for VAL001.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/08/respiratorius-h1-marked-by-positive-patent-decision-and-secured-financing/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om Respiratorius

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!